Sarah K. Fehling

Hans Meerwein Str. 2
Marburg An Der Lahn, HE 35043, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Lassa Virus Infection of Primary Human Airway Epithelial Cells.

Lassa Virus Infection of Primary Human Airway Epithelial Cells.

Journal: Viruses

Published: March 10, 2025

Distinct negative-sense RNA viruses induce a common set of transcripts encoding proteins forming an extensive network.

Distinct negative-sense RNA viruses induce a common set of transcripts encoding proteins forming an extensive network.

Journal: Journal of virology

Published: September 16, 2024

Hexestrol, an estrogen receptor agonist, inhibits Lassa virus entry.

Hexestrol, an estrogen receptor agonist, inhibits Lassa virus entry.

Journal: Journal of virology

Published: May 29, 2024

Serological evidence of zoonotic filovirus exposure among bushmeat hunters in Guinea.

Serological evidence of zoonotic filovirus exposure among bushmeat hunters in Guinea.

Journal: Nature communications

Published: February 10, 2022

Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis.

Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis.

Journal: Frontiers in immunology

Published: January 18, 2022

Proteomic landscape of SARS-CoV-2- and MERS-CoV-infected primary human renal epithelial cells.

Proteomic landscape of SARS-CoV-2- and MERS-CoV-infected primary human renal epithelial cells.

Journal: Life science alliance

Published: January 11, 2022

CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.

CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.

Journal: Viruses

Published: July 22, 2021

Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study.

Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study.

Journal: The Lancet. Infectious diseases

Published: May 18, 2020

Ebola Virus Neutralizing Antibodies in Dogs from Sierra Leone, 2017.

Ebola Virus Neutralizing Antibodies in Dogs from Sierra Leone, 2017.

Journal: Emerging infectious diseases

Published: March 19, 2020

Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity.

Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity.

Journal: NPJ vaccines

Published: January 29, 2020

Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies.

Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies.

Journal: Scientific reports

Published: January 02, 2020

Postexposure Prophylaxis With rVSV-ZEBOV Following Exposure to a Patient With Ebola Virus Disease Relapse in the United Kingdom: An Operational, Safety, and Immunogenicity Report.

Postexposure Prophylaxis With rVSV-ZEBOV Following Exposure to a Patient With Ebola Virus Disease Relapse in the United Kingdom: An Operational, Safety, and Immunogenicity Report.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: July 19, 2019

Showing 1-12 of 29

Last Updated: 09/26/2026